You have 9 free searches left this month | for more free features.

second primary cancer

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Recurrent Cancer, Primary Cancer, Second Cancer Trial in Lyon (Dostarlimab)

Not yet recruiting
  • Recurrent Cancer
  • +2 more
  • Lyon, France
    Centre Léon Bérard
May 12, 2023

AI & Radiomics for Stratification of Lung Nodules After

Recruiting
  • Indeterminate Pulmonary Nodules
  • +3 more
  • Non-Interventional Study
  • London, United Kingdom
  • +1 more
May 17, 2022

Pediatric Primary Immune Thrombocytopenia (ITP)

Recruiting
  • Primary Immune Thrombocytopenia
  • data collection
  • Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Oct 31, 2023

DNA Repair and Genetic Susceptibility to Lung Cancer

Active, not recruiting
  • Lung Cancer
  • +2 more
  • Blood draw and Questionnaires
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 3, 2022

Liver Metastases, Liver Cancer, Liver Tumors Trial in Warsaw (PVE, LVD, ALPPS)

Not yet recruiting
  • Liver Metastases
  • +3 more
  • PVE
  • +2 more
  • Warsaw, Mazowieckie, Poland
    Second Department of Clinical Radiology
Sep 17, 2023

Metastatic Cancers, Fatigue Trial in Houston (Psychoeducational Intervention, Open Label Placebo, Psychoeducational

Not yet recruiting
  • Metastatic Cancers
  • Fatigue
  • Psychoeducational Intervention
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Centerr
Oct 10, 2023

Metastatic Cancer, Solid Tumor Cancer, Lymphoproliferative Disorders Trial in Boulder (Written Exposure Therapy)

Recruiting
  • Metastatic Cancer
  • +5 more
  • Written Exposure Therapy
  • Boulder, Colorado
    University of Colorado Boulder
Sep 13, 2023

Recurrent Head and Neck Squamous Cell Carcinoma Trial in Atlanta, Cleveland, Milwaukee (IMRT, Nivolumab)

Active, not recruiting
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • IMRT
  • Nivolumab
  • Atlanta, Georgia
  • +3 more
Jan 10, 2023

Primary Malignant Brain Tumor Trial in China (ABM-1310)

Not yet recruiting
  • Primary Malignant Brain Tumor
  • Beijing, Beijing, China
  • +3 more
May 28, 2023

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in New York (NY-ESO-1 OLP4, NY-ESO-1 OLP4 +

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • NY-ESO-1 OLP4
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Cancer, Cancer, Treatment-Related, Medication Adherence Trial in Chicago (Oncotool Intervention (symptom reporting + TKI

Completed
  • Cancer
  • +4 more
  • Oncotool Intervention (symptom reporting + TKI education)
  • Oncotool Control (health information)
  • Chicago, Illinois
    Northwestern University
Jan 25, 2023

Rectal Cancer Trial (Vein ligation first, Artery ligation first)

Not yet recruiting
  • Rectal Cancer
  • Vein ligation first
  • Artery ligation first
  • (no location specified)
Mar 29, 2023

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Houston (Paclitaxel, Carboplatin, Bevacizumab)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 13, 2023

Breast Cancer, Cancer, Treatment-Related, Pain Cancer Trial (I-Can-Manage-Pain after cancer (Pain Management Program))

Not yet recruiting
  • Breast Cancer
  • +2 more
  • I-Can-Manage-Pain after cancer (Pain Management Program)
  • (no location specified)
Oct 20, 2023

Epithelial Ovarian Carcinoma Stage III, Epithelial Ovarian Carcinoma Stage IV, Fallopian Tube Carcinoma Stage III Trial in China

Recruiting
  • Epithelial Ovarian Carcinoma Stage III
  • +5 more
  • nab-paclitaxel combined with carboplatin
  • Guangzhou, Guangdong, China
  • +10 more
Feb 19, 2023

Fatigue, Cancer, Treatment-Related Trial (Redsenol-1 Plus, Placebo)

Not yet recruiting
  • Fatigue
  • Cancer, Treatment-Related
  • Redsenol-1 Plus
  • Placebo
  • (no location specified)
Dec 15, 2022

NSCLC, HNSCC, Melanoma Trial (CJRB-101, Pembrolizumab injection)

Not yet recruiting
  • NSCLC
  • +5 more
  • (no location specified)
Jun 1, 2023

Colorectal Cancer, Liver Metastases, Liver Metastasis Colon Cancer Trial in Amsterdam (Neoadjuvant systemic therapy (CAPOX+/-B

Recruiting
  • Colorectal Cancer
  • +5 more
  • Neoadjuvant systemic therapy (CAPOX+/-B FOLFOX+/-B FOLFIRI+/-B)
  • Repeat local treatment
  • Amsterdam, Netherlands
    Amsterdam UMC
May 5, 2023

Head Neck Cancer Trial in Oslo (FDG-PET guided dose painting)

Active, not recruiting
  • Head and Neck Cancer
  • FDG-PET guided dose painting
  • Oslo, Norway
    Oslo University Hospital
Apr 29, 2022

Previously Treated Primary Immune Thrombocytopenia Trial in China (rhTPO, Eltrombopag)

Recruiting
  • Previously Treated Primary Immune Thrombocytopenia
  • Guangzhou, Guangdong, China
  • +15 more
Jan 24, 2023

Cancer, Treatment-Related, Tumor of Breast, Systemic Inflammatory Response Trial in Roma (cryoablation)

Completed
  • Cancer, Treatment-Related
  • +3 more
  • cryoablation
  • Roma, Italy
    Sapienza University of Rome
Feb 13, 2023

High Grade Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine, Carboplatin)

Not yet recruiting
  • High Grade Ovarian Cancer
  • +2 more
  • (no location specified)
Jul 11, 2022

Palliative Primary Tumor Resection in Minimally Symptomatic

Recruiting
  • Colorectal Neoplasms
  • +12 more
  • Moscow, Russian Federation
    Ryzhikh National Medical Research Center of Coloproctology
Apr 2, 2022

Cancer Pain, Cancer, Distress, Emotional Trial in Seongnam-si (Mindfulness-Based Cognitive-behavioral Therapy for Distress)

Not yet recruiting
  • Cancer Pain
  • +5 more
  • Mindfulness-Based Cognitive-behavioral Therapy for Distress
  • Seongnam-si, Kyeonggi-do, Korea, Republic of
    CHA Bundang Medical Center
Mar 2, 2023

Lung Cancer Trial in United States (cytology specimen collection procedure, immunoenzyme technique, study of high risk factors)

Completed
  • Lung Cancer
  • cytology specimen collection procedure
  • +2 more
  • Tampa, Florida
  • +4 more
Jun 8, 2022